Avalo Therapeutics, Inc. (AVTX)

NASDAQ: AVTX · Real-Time Price · USD

19.70

-0.13 (-0.66%)

Aug 24, 2026, 9:28 AM EDT - Market open

Avalo Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	85.38	15.86	134.55	7.42	13.17	54.59
Short-Term Investments	314.89	82.48	-	-	-	-
Cash & Short-Term Investments	400.28	98.34	134.55	7.42	13.17	54.59
Cash Growth	253.41%	-26.91%	1714.51%	-43.71%	-75.87%	188.52%
Accounts Receivable	-	-	-	-	-	1.06
Other Receivables	-	-	-	0.14	1.92	3.74
Receivables	-	-	-	0.14	1.92	4.8
Inventory	-	-	-	-	0.02	0.04
Prepaid Expenses	7.61	6.91	4.33	0.84	1.29	2.37
Restricted Cash	0.05	0.04	0.02	0	0.02	0.05
Total Current Assets	407.93	105.29	138.89	8.4	16.42	61.85
Property, Plant & Equipment	0.29	0.46	1.21	1.97	2.41	2.7
Goodwill	10.5	10.5	10.5	10.5	14.41	14.41
Other Intangible Assets	-	-	-	-	-	0.04
Other Long-Term Assets	0.18	0.21	0.13	0.13	0.13	1.23
Total Assets	490.78	116.46	150.73	20.99	33.37	80.21

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	3.35	0.14	0.28	0.45	2.88	3.37
Accrued Expenses	7.54	12.41	5.22	1.76	10.51	14.29
Current Portion of Long-Term Debt	-	-	-	-	5.93	-
Current Portion of Leases	0.24	0.39	0.57	0.54	0.53	0.49
Current Unearned Revenue	-	-	-	-	0.09	-
Other Current Liabilities	10	-	0.89	1.87	2.17	1.74
Total Current Liabilities	21.13	12.94	6.96	4.62	22.11	19.89
Long-Term Debt	-	-	-	-	13.49	32.83
Long-Term Leases	-	0.04	0.35	1.37	1.71	2.02
Long-Term Deferred Tax Liabilities	0.46	0.43	0.27	0.16	0.14	0.11
Other Long-Term Liabilities	20.53	20	10.12	7.55	6.83	2.28
Total Liabilities	42.12	33.41	17.7	13.69	44.28	57.13

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.05	0.02	0.01	0	-	0.01
Additional Paid-In Capital	953.7	531.49	503.29	342.44	292.91	285.24
Retained Earnings	-504.51	-448.52	-370.26	-335.13	-303.82	-262.17
Comprehensive Income & Other	-0.58	0.07	-	-	-	-
Shareholders' Equity	448.66	83.05	133.03	7.3	-10.92	23.08
Total Liabilities & Equity	490.78	116.46	150.73	20.99	33.37	80.21

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	0.24	0.43	0.92	1.9	21.66	35.34
Net Cash (Debt)	400.03	97.91	133.63	5.51	-8.49	19.25
Net Cash Growth	255.32%	-26.73%	2324.31%	-	-	10.28%
Net Cash Per Share	16.65	7.30	17.83	19.85	-216.49	531.87
Filing Date Shares Outstanding	53.63	22.79	10.67	1.03	0.06	0.04
Total Common Shares Outstanding	52.9	18.51	10.47	0.8	0.04	0.04
Working Capital	386.8	92.35	131.93	3.78	-5.7	41.96
Book Value Per Share	8.48	4.49	12.70	9.11	-277.78	589.35
Tangible Book Value	438.16	72.55	122.53	-3.2	-25.32	8.64
Tangible Book Value Per Share	8.28	3.92	11.70	-3.99	-644.47	220.48
Machinery	-	0.14	0.28	0.28	0.34	0.24
Leasehold Improvements	-	0.24	0.9	0.9	0.74	0.74

SEC Filings: 10-K · 10-Q